[What do we expect after ENRICA and IBERICAN with new therapeutics in CKD?]
Hipertens Riesgo Vasc
.
2023 Jul-Sep;40(3):158-160.
doi: 10.1016/j.hipert.2023.03.002.
Epub 2023 May 9.
[Article in Spanish]
Author
M A María-Tablado
1
Affiliation
1
Grupo de trabajo HTA de semFYC, Barcelona, España. Electronic address: docencialosfresnos@hotmail.com.
PMID:
37169711
DOI:
10.1016/j.hipert.2023.03.002
No abstract available
Publication types
Letter
MeSH terms
Cardiovascular Diseases*
Humans
Renal Insufficiency, Chronic* / therapy
Risk Factors